期刊文献+

应用NCCLS EP10-A2文件初步评价HA8160糖化血红蛋白仪的性能 被引量:2

Preliminary evaluation of HA8160 analyzer for hemoglobin a1c detection by EP10-A2
下载PDF
导出
摘要 目的初步评价HA8160糖化血红蛋白分析仪测定糖化血红蛋白(HbA1c)的临床应用性能。方法按照美国临床实验室标准化委员会(NCCLS)颁布的EP10-A2文件,连续5 d按特定顺序测定高、中、低浓度样本的HbA1c,采用Excel软件计算测定结果的偏差、总不精密度,以及截距、斜率、非线性、携带污染、漂移。结果当样本高中低靶值分别为:10.30%、7.75%和5.20%时,其偏差分别为0.22%,0.22%,0.23%,总不精密度分别为0.776%,1.169%,1.427%,测定值与靶值的线性良好(y=0.9987x+0.2312,r2=0.9985);截距为0.235,与靶值有恒定误差(P<0.01),斜率、非线性、携带污染、漂移分别为0.998,0.468,0.001和0.003,差异均无统计学意义(P>0.01)。结论该分析仪测定HbA1c的准确度和精密度良好,均在允许范围内,线性良好,携带污染低,稳定性好,性能指标符合临床应用要求。 Objective To preliminarily evaluate the performance of HA8160 analyzer for hemoglobin A1c detection.Methods According to the NCCLS Document EP10-A2,HbA1c of 3 specimens at high,middle and low concentrations were measured by HA8160 analyzer by a special order in 5 days.Microsoft Office Excel was used for analyzing the bias,the total imprecision,intercept,slope rate,nonlinearity,carryover contamination and drift.Results When the concentration of HbA1c at high-,middle-,and low-value was 10.3%,7.75% and 5.2%,the bias was 0.22%,0.22% and 0.23%.The total imprecision was 0.776%,1.169% and 1.427% respectively.The regression equation was y = 0.9987x + 0.2312,r2 = 0.9985.The intercept showed constant error was 0.235.The slope rate,nonlinearity,carryover contamination and drift was 0.998,0.468,0.001,0.003 respectively,which did not show significant difference(P 0.01).Conclusion Both the bias and precision of HA8160 analyzer were within the acceptable range,good linearity,nonlinearity,low carryover contamination and good stability.All these indexes were within allowed limit.The performance of this analyzer can satisfy clinical application requirements.
出处 《临床和实验医学杂志》 2013年第11期832-834,共3页 Journal of Clinical and Experimental Medicine
关键词 糖化血红蛋白分析仪 EP10-A2 初步评价 HbA1c analyzer EP10-A2 Preliminary evaluation
  • 相关文献

参考文献4

二级参考文献25

  • 1毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:153
  • 2高月亭,陈涛,刘汉欣,刘忠民,李宁,肖洪广.应用EP10-A初步评价XI-921型电解质分析仪[J].现代临床医学生物工程学杂志,2006,12(6):507-509. 被引量:4
  • 3U. S. Department of Health and Human Services, Centers for Medicare&Medicaid Services. Clinical laboratory improvement amendments of 1988 :final rule [ S]. Fed Register,2003:3704.
  • 4ISO 15189.医学实验室质量和能力认可准则[s].中国合格评定国家认可委员会,2008:1-36.
  • 5CLSI. EP5-A. Evaluation of precision performance of clinical chemistry devices [ S]. 1999 : 1-28.
  • 6CLSI. EP6-A2. Evaluation of the linearity of quantative analytical methods [ S ]. 2003 : 1-47.
  • 7CLSI. C28-A2. How to define and determine reference intervals in the clinical laboratory [ S ]. 2000 : 1-31.
  • 8CLSI. EP17-A. Protocols for determination of limits of detection and limits of quanitation [ S]. 2004 : 1-39.
  • 9CLSI. EP7-A2. Interference testing in clinical chemistry[ S]. 2005: 1-47.
  • 10Broughton P,Gowenlock A,McCormack J,et al. A revised scheme for the evaluation of automatic instruments for use in clinical chemistry [ J ]. Ann Clin Biochem,2007,11 ( 6 ) : 207-218.

共引文献187

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部